← Back to Search

Organic Infant Formula

Organic Infant Formula for Healthy Growth

N/A
Waitlist Available
Led By Samantha Bostrom, MD
Research Sponsored by Nara Organics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study day 1 to study day 112
Awards & highlights

Study Summary

This study is evaluating whether a new formula may help infants grow appropriately.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study day 1 to study day 112
This trial's timeline: 3 weeks for screening, Varies for treatment, and study day 1 to study day 112 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anthropometry Z-scores.
Formula intake.
Head circumference.
+2 more
Secondary outcome measures
Formula tolerance.
Gastrointestinal characteristic.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Investigational FormulaExperimental Treatment1 Intervention
An organic milk-based infant formula.
Group II: Control FormulaActive Control1 Intervention
A standard, milk-based, infant formula.

Find a Location

Who is running the clinical trial?

Paidion Research, Inc.Industry Sponsor
9 Previous Clinical Trials
1,735 Total Patients Enrolled
Nara OrganicsLead Sponsor
Kumar Ilangovan, MDStudy DirectorPaidion Research, Inc.
1 Previous Clinical Trials
131 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~42 spots leftby Apr 2025